Pharmaceutical Research

药物研究

• 批准号: 8180924
• 负责人: HERBERT KIM LYERLY
• 金额: $ 10.51万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-03 至 2014-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8180924
• 关键词: Accountability; Accounting; Address; Adherence; Animal Experiments; Antineoplastic Agents; Area; Arts; Authorization documentation; Award; Back; Basic Science; Biological; Biological Assay; Biological Markers; Blood Cells; Brain; Cancer Therapy Evaluation Program; Cancer and Leukemia Group B; Cell Culture Techniques; Clinic; Clinical; Clinical Protocols; Clinical Research; Clinical Trials Design; Collection; Complex; Conduct Clinical Trials; Consultations; Data; Development; Documentation; Dose; Drug Delivery Systems; Drug Exposure; Drug Kinetics; Drug toxicity; Drug usage; Education; Eligibility Determination; Ensure; Equipment and supply inventories; Evaluation; Funding; Grant; Guidelines; Gynecologic Oncology Group; Hour; Human Resources; Individual; Information Systems; Inpatients; Institutes; Investigational Drugs; Investigational Therapies; Laboratories; Laboratory Personnel; Liquid substance; Malignant Neoplasms; Measures; Medical center; Metabolism; Methodology; Methods; Modeling; Molecular Weight; Monograph; National Surgical Adjuvant Breast and Bowel Project; Patients; Pharmaceutical Preparations; Pharmacodynamics; Pharmacologic Substance; Pharmacotherapy; Pharmacy facility; Phase; Plasma; Population; Prevention; Procedures; Process; Protocols documentation; Publications; Radiation Therapy Oncology Group; Records; Reporting; Research; Research Activity; Research Ethics Committees; Research Personnel; Resource Sharing; Resources; Review Committee; Sampling; Services; Shipping; Ships; Structure; Techniques; Technology; Tissues; Toxic effect; Translational Research; Workload; Writing; absorption; analytical method; anticancer research; cancer pharmacology; chemotherapy; cost effective; cytokine; design; drug development; drug discovery; drug modification; high standard; instrumentation; interest; member; new therapeutic target; novel; pre-clinical; preclinical study; programs; research study; sample collection; treatment response